Study of a new drug for advanced solid tumors
Part of Cancer clinical trials.
This trial tests a new drug that may help people with advanced solid tumors that have not responded to other treatments. The drug is given as an injection and aims to stop cancer growth.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You have an advanced solid tumor (like soft tissue sarcoma, head and neck cancer, or melanoma) that has not responded to at least two prior treatments.
- You are able to take care of yourself (ECOG score 0-1) and expected to live at least 3 more months.
- You have not had chemotherapy, radiation, or surgery in the last 28 days (or 6 weeks for certain drugs).
- Your blood counts, liver, kidney, and heart function are within acceptable ranges.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-stage trial tests a new mRNA-based drug designed to help your immune system fight advanced cancers that haven't responded to standard treatments. The study measures safety, tolerability, and whether it can slow or shrink your tumor.
This trial tests a new medication for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This trial tests a new experimental drug (called NCP-IL-22BP mRNA) for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe, tolerable, and maybe effective against the cancer.
This trial tests a new oral drug (CS231295) for people with advanced solid tumors who have run out of standard options. It aims to see how safe the drug is and how well it controls the cancer, and may slow tumor growth. You must be in reasonably good health with adequate organ function.
This trial tests a new investigational drug (JNJ-87890387) for people with certain advanced solid tumors that have spread or cannot be removed by surgery. It aims to see if the drug is safe and effective.
This trial is testing whether a new drug called CT7439 can help people with advanced solid tumors that have not responded to other treatments. It is a phase 1/2 study that also checks the drug's safety and how well it works.
Hear when a new Solid Tumor Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.